Panacea Innovation Ltd
SEC insider (Form 3/4/5 filer). CIK 0002010692. 10% Owner at Atara Biotherapeutics, Inc. (ATRA). 8 reported Form 4/5 transactions since Sep 2024; latest on May 7, 2026. Located in GRAND CAYMAN.
Companies Panacea Innovation Ltd has filed insider reports for
- Atara Biotherapeutics, Inc. (ATRA): 10% Owner
Panacea Innovation Ltd
CIK: 0002010692
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Atara Biotherapeutics, Inc.
Discretionary Trading P&L
Holdings
Transaction History (8 total)
- May 7, 2026ATRA
Atara Biotherapeutics, Inc.
SaleIndirect313.4K shares at avg. $10.10$3.2M - Mar 17, 2026ATRA
Atara Biotherapeutics, Inc.
ExerciseIndirect259.2K shares at avg. $0.00$25.916 - Mar 17, 2026ATRA
Atara Biotherapeutics, Inc.
Tax PaymentIndirect5 shares at avg. $5.23$26.15 - Jan 12, 2026ATRA
Atara Biotherapeutics, Inc.
SaleIndirect80.6K shares at avg. $6.07$489K - Nov 28, 2025ATRA
Atara Biotherapeutics, Inc.
ExerciseIndirect48.7K shares at avg. $0.00$4.874 - Nov 28, 2025ATRA
Atara Biotherapeutics, Inc.
Tax PaymentIndirect1 shares at avg. $14.03$14.03 - Aug 15, 2025ATRA
Atara Biotherapeutics, Inc.
PurchaseIndirect55K shares at avg. $12.19$670K - Jul 17, 2025ATRA
Atara Biotherapeutics, Inc.
PurchaseIndirect19.3K shares at avg. $9.64$186K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| May 7, 2026 | ATRA Atara Biotherapeutics, Inc. | Sale | 313,446 | $10.10 | $3,165,021 | Indirect |
| Mar 17, 2026 | ATRA Atara Biotherapeutics, Inc. | Exercise | 259,163 | $0.00 | $26 | Indirect |
| Mar 17, 2026 | ATRA Atara Biotherapeutics, Inc. | Tax Payment | 5 | $5.23 | $26 | Indirect |
| Jan 12, 2026 | ATRA Atara Biotherapeutics, Inc. | Sale | 80,554 | $6.07 | $489,019 | Indirect |
| Nov 28, 2025 | ATRA Atara Biotherapeutics, Inc. | Exercise | 48,737 | $0.00 | $5 | Indirect |
| Nov 28, 2025 | ATRA Atara Biotherapeutics, Inc. | Tax Payment | 1 | $14.03 | $14 | Indirect |
| Aug 15, 2025 | ATRA Atara Biotherapeutics, Inc. | Purchase | 55,000 | $12.19 | $670,423 | Indirect |
| Jul 17, 2025 | ATRA Atara Biotherapeutics, Inc. | Purchase | 19,335 | $9.64 | $186,372 | Indirect |
1-8 of 8 transactions